Skip to content

Gene pathway responsible for peripheral nervous system regeneration identified.

It is known that the regenerative capacity of the injured central nervous system (CNS) in adult mammals is severely limited, yet axons in the peripheral nervous system (PNS) regrow, albeit to a limited extent, after injury.  Researchers hypothesize that differences in the regenerative potential between injured PNS neurons and injured CNS neurons reflect major differences in intrinsic transcriptional networks, however, these are yet to be mapped.  Now, a study from researchers led by UCLA has identified a specific network of genes that promote repair in the peripheral nervous system in a mouse model; importantly, this network doesn’t exist in the central nervous system. The team state that their findings also led them to identify a drug that promotes nerve regeneration in the central nervous system. The opensource study is published in the journal Neuron.

Previous studies support the concept that specific intrinsic molecular differences contribute to the divergent neuronal growth after PNS and CNS injuries.  This has been shown by the manipulation of individual candidate genes induced in neurons by PNS, but not CNS, injury, which can promote limited CNS regrowth after injury.

However, these findings also suggest that multiple pathways act in parallel to stimulate neuronal regeneration after injury.  The current study shows that the expression of transcription factors is coordinately upregulated following PNS injury, but not after CNS injury, consistent with the theory that coordinate regulation of this core network, rather than individual components, is necessary for axon regrowth.

The current study measured the response of gene regulation at the level of messenger RNA, or mRNA, in each instance of injury.  The lab state that they developed a unique set of algorithms to look at the interactions of various groups of genes and the order in which they were expressed.  Results identified common patterns that correlate with regeneration in the peripheral nervous system, and within those patterns the group were able to identify several genes not previously known that enhanced repair.  In contrast, data findings show that these patterns are not present in the central nervous system.

The team surmise that theirs is a major advance, identifying the entire network of pathways turned on in the peripheral nervous system when it regenerates, key aspects of which are missing in the central nervous system.  For the future, the researchers state that as a proof of principle that gene expression could be used to screen for drugs that mimic the same pattern, they identified the drug Ambroxol, which significantly enhanced central nervous system repair.

Source: UCLA
Targeting Candidate RAG Regulatory Network Using Small Molecules. Gene expression signatures after PNS injury were used to query drug-related expression profiles in the Connectivity Map. Using a pattern-matching algorithm, we selected three drugs (ambroxol, disulfiram, and lasalocid) based on enrichment and specificity scores. PPI (edges) network of co-expressed and differentially expressed genes (nodes) after PNS injury is shown. Upregulation (red) and downregulation (green) after SN lesion; upregulation (blue) and downregulation (purple) after ambroxol treatment (from Connectivity Map). A Systems-Level Analysis of the Peripheral Nerve Intrinsic Axonal Growth Program. Geschwind et al 2016.
Targeting Candidate RAG Regulatory Network Using Small Molecules. Gene expression signatures after PNS injury were used to query drug-related expression profiles in the Connectivity Map. Using a pattern-matching algorithm, we
selected three drugs (ambroxol, disulfiram, and lasalocid) based on enrichment and specificity scores.
PPI (edges) network of co-expressed and differentially expressed genes (nodes) after PNS injury is shown. Upregulation (red) and downregulation (green) after SN lesion; upregulation (blue) and downregulation (purple) after ambroxol treatment (from Connectivity Map). A Systems-Level Analysis of the Peripheral Nerve Intrinsic Axonal Growth Program. Geschwind et al 2016.

 

Healthinnovations View All

Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.

Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.

Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.

Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.

Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.

An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.

Leave a Reply

Translate »